Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C38H46Cl2N6O8S |
Molecular Weight | 817.778 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@H](N(C)C(=O)CC1=CC=C(NC(=O)NC2=CC=CC=C2C)C=C1)C(=O)NCC[C@H](NC(=O)[C@@H]3CCCN3S(=O)(=O)C4=CC(Cl)=CC(Cl)=C4)C(O)=O
InChI
InChIKey=MNQBPRHHZPXCKZ-ZDCRTTOTSA-N
InChI=1S/C38H46Cl2N6O8S/c1-23(2)18-33(45(4)34(47)19-25-11-13-28(14-12-25)42-38(52)44-30-9-6-5-8-24(30)3)35(48)41-16-15-31(37(50)51)43-36(49)32-10-7-17-46(32)55(53,54)29-21-26(39)20-27(40)22-29/h5-6,8-9,11-14,20-23,31-33H,7,10,15-19H2,1-4H3,(H,41,48)(H,43,49)(H,50,51)(H2,42,44,52)/t31-,32-,33-/m0/s1
Molecular Formula | C38H46Cl2N6O8S |
Molecular Weight | 817.778 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/12626659Curator's Comment: Description was created based on several sources, including http://adisinsight.springer.com/drugs/800019793
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12626659
Curator's Comment: Description was created based on several sources, including http://adisinsight.springer.com/drugs/800019793
BIO-5192 is a highly selective and potent (KD of <10 pM) inhibitor of integrin alpha 4 beta 1. The high affinity
for integrin alpha 4 beta 1 results from an extremely slow dissociation rate of
the inhibitor from the integrin/inhibitor complex, with a dissociation
half-life of >12 h for both the unactivated and
activated integrin. Preclinical trials in multiple sclerosis in USA were underway, but no recent development of BIO-5192 or its pegylated form has been reported; it appears that development has been discontinued.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/18926823
Rats: rats were treated intravenously with BIO-5192 (10 mg/kg)
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19571319
BIO-5192 (1 ug/mL) reduced both untreated and phorbol 12-myristate 13-acetate–stimulated murine A20 lymphoma cell binding to fibronectin-coated plates by 43% and 36%, respectively, indicating that BIO-5192 blocks binding to multiple activation states of VLA-4
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:27:34 GMT 2023
by
admin
on
Sat Dec 16 09:27:34 GMT 2023
|
Record UNII |
55W0N209OS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
327613-57-0
Created by
admin on Sat Dec 16 09:27:34 GMT 2023 , Edited by admin on Sat Dec 16 09:27:34 GMT 2023
|
PRIMARY | |||
|
10350459
Created by
admin on Sat Dec 16 09:27:34 GMT 2023 , Edited by admin on Sat Dec 16 09:27:34 GMT 2023
|
PRIMARY | |||
|
55W0N209OS
Created by
admin on Sat Dec 16 09:27:34 GMT 2023 , Edited by admin on Sat Dec 16 09:27:34 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |